Policy

What does DOGE, a sort-of government agency named after a memecoin and led by billionaire Elon Musk, have to do with the U.S. federal health care apparatus? Apparently, a great deal.

Multiple agencies are seeing hundreds or even thousands of employees fired

U.S. health care system gets failing grade for supporting primary care, say Milbank Memorial Fund and the Physicians Foundation.

Physicians have complained that Medicare reimbursement rates have not kept pace with inflation, and now in 2025, are dealing with a 2.83% reimbursement cut. There's little chance of relief in sight. How did we get here?

Public benefit corporation announces developments for 2025.

Some enrollments were costing the government more than $3,000 per enrollee

Research estimates health care spending by conditions, age, types of care, down to county level.

Most dismissed employees are non-union employees with less than a year in their position

What will the plans of RFK Jr., Trump’s new secretary of health and human services, mean to physicians and patients?

The Senate voted 52-48 in favor of Kennedy — Sen. Mitch McConnell the lone Republican to oppose Kennedy’s nomination.

Several leading physician groups issued a statement in support of the Medicaid program amid proposals to implement budget cuts, structural changes.

Bargaining for widely used prescription drugs may save money for Medicare, but AAR wants seniors to see better prices at the pharmacy counter.

The Senate voted along party lines to advance the nomination of Robert F. Kennedy Jr. for health secretary to the floor for a final vote, likely Thursday.

A discussion about the Medicare Drug Price Negotiation Program with Adina Lasser, director of public policy and government affairs with the Alliance for Aging Research.

A study of the medical economics of ultraprocessed foods, diabetes and pharmaceutical revenues.

House Ways and Means Committee considers suggestions on Making America Healthy Again.

A discussion about the Medicare Drug Price Negotiation Program with Adina Lasser, director of public policy and government affairs with the Alliance for Aging Research.

A discussion about the Medicare Drug Price Negotiation Program with Adina Lasser, director of public policy and government affairs with the Alliance for Aging Research.

What new treatments mean for practices and patients.

Rise means Fed unlikely to cut rates anytime soon

A discussion about the Medicare Drug Price Negotiation Program with Adina Lasser, director of public policy and government affairs with the Alliance for Aging Research.

A discussion about the Medicare Drug Price Negotiation Program with Adina Lasser, director of public policy and government affairs with the Alliance for Aging Research.

It remains unclear how Trump's executive order on workforce reductions will impact federal health agencies.

A discussion about the Medicare Drug Price Negotiation Program with Adina Lasser, director of public policy and government affairs with the Alliance for Aging Research.

A discussion about the Medicare Drug Price Negotiation Program with Adina Lasser, director of public policy and government affairs with the Alliance for Aging Research.

A discussion about the Medicare Drug Price Negotiation Program with Adina Lasser, director of public policy and government affairs with the Alliance for Aging Research.

Congress could rectify the situation in upcoming spending bill or with pending legislation.

Yale researchers revealed $2.6 trillion in payouts over two decades, raising concerns about affordability and reinvestment.

Legislators question Health and Human Services leaders about potential for wrongful disclosure of private health information.

New York’s licensure rules can complicate cross-state medical practice with potential widespread professional repercussions.